IL136028A0 - Novel oral dosage form for carvedilol - Google Patents

Novel oral dosage form for carvedilol

Info

Publication number: IL136028A0
Authority: IL; Israel
Prior art keywords: carvedilol; dosage form; oral dosage; novel oral; novel
Prior art date: 1997-11-12

Application number

IL13602898A

Original Assignee

Boehringer Mannheim Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-12

Filing date

1998-11-12

Publication date

2001-05-20

1998-11-12 Application filed by Boehringer Mannheim Pharm Corp filed Critical Boehringer Mannheim Pharm Corp

2001-05-20 Publication of IL136028A0 publication Critical patent/IL136028A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Indole Compounds (AREA)

IL13602898A 1997-11-12 1998-11-12 Novel oral dosage form for carvedilol IL136028A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6545697P	1997-11-12	1997-11-12
PCT/US1998/024102 WO1999024017A1 (en)	1997-11-12	1998-11-12	Novel oral dosage form for carvedilol

Publications (1)

Publication Number	Publication Date
IL136028A0 true IL136028A0 (en)	2001-05-20

Family

ID=22062830

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13602898A IL136028A0 (en)	1997-11-12	1998-11-12	Novel oral dosage form for carvedilol

Country Status (14)

Country	Link
EP (1)	EP1030651A4 (en)
JP (1)	JP2001522794A (en)
KR (1)	KR20010031952A (en)
CN (1)	CN1285738A (en)
AU (1)	AU751117B2 (en)
BR (1)	BR9814127A (en)
CA (1)	CA2309542A1 (en)
HU (1)	HUP0004345A3 (en)
IL (1)	IL136028A0 (en)
NO (1)	NO20002439D0 (en)
NZ (1)	NZ504418A (en)
PL (1)	PL340456A1 (en)
TR (1)	TR200001362T2 (en)
WO (1)	WO1999024017A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040151772A1 (en)	2002-11-08	2004-08-05	Egalet A/S	Controlled release carvedilol compositions
AU2003288608A1 (en) *	2002-12-20	2004-07-14	Ranbaxy Laboratories Limited	Controlled release, multiple unit drug delivery systems
JP5072364B2 (en)	2003-11-25	2012-11-14	スミスクラインビーチャム（コーク）リミテッド	Carvedilol free base, carvedilol salt, anhydrous form or solvate thereof, corresponding pharmaceutical composition, controlled release formulation and treatment or delivery method
EP1686967A4 (en) *	2003-11-25	2012-08-08	Smithkline Beecham Cork Ltd	Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
EP2010162A4 (en) *	2006-04-03	2013-01-09	Isa Odidi	Drug delivery composition
TWI415604B (en)	2009-09-29	2013-11-21	Tsh Biopharm Corp Ltd	Regulated release of caffetilol dosage form
WO2011102504A1 (en) *	2010-02-22	2011-08-25	第一三共株式会社	Sustained-release solid preparation for oral use
WO2011102505A1 (en) *	2010-02-22	2011-08-25	第一三共株式会社	Sustained-release solid preparation for oral use
JP5714562B2 (en) *	2010-02-22	2015-05-07	第一三共株式会社	Oral sustained-release solid preparation
EP2893928B1 (en)	2012-09-03	2018-10-24	Daiichi Sankyo Company, Limited	Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
KR102158339B1 (en) *	2016-02-05	2020-09-21	삼진제약주식회사	Carvedilol immediate release formulation having improved madescent
KR102492147B1 (en)	2020-12-30	2023-01-26	단국대학교 천안캠퍼스 산학협력단	Carvedilol loaded solid oral compositions using self-nanoemulsifying drug delivery system and methods for their preparation
KR102525298B1 (en)	2020-12-30	2023-04-25	단국대학교 천안캠퍼스 산학협력단	Carvedilol loaded solid dispersion with increased oral bioavailability and methods for their preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2815926A1 (en) *	1978-04-13	1979-10-18	Boehringer Mannheim Gmbh	NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
JPS5598120A (en) *	1979-01-16	1980-07-25	Shin Etsu Chem Co Ltd	Preparation of drug having enteric coating
CA1146866A (en) *	1979-07-05	1983-05-24	Yamanouchi Pharmaceutical Co. Ltd.	Process for the production of sustained release pharmaceutical composition of solid medical material
US4680323A (en) *	1983-12-01	1987-07-14	Hans Lowey	Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
EP0554306B1 (en) *	1990-10-23	1996-02-21	Davband Pty. Limited	Back support for a chair or seat
US5760069A (en) *	1995-02-08	1998-06-02	Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1	Method of treatment for decreasing mortality resulting from congestive heart failure
DE19637082A1 (en) *	1996-09-12	1998-03-19	Boehringer Mannheim Gmbh	Rapidly disintegrating pellets

1998
- 1998-11-12 KR KR1020007005059A patent/KR20010031952A/en not_active Ceased
- 1998-11-12 HU HU0004345A patent/HUP0004345A3/en unknown
- 1998-11-12 TR TR2000/01362T patent/TR200001362T2/en unknown
- 1998-11-12 NZ NZ504418A patent/NZ504418A/en unknown
- 1998-11-12 EP EP98958546A patent/EP1030651A4/en not_active Withdrawn
- 1998-11-12 PL PL98340456A patent/PL340456A1/en unknown
- 1998-11-12 IL IL13602898A patent/IL136028A0/en not_active IP Right Cessation
- 1998-11-12 CN CN98813082A patent/CN1285738A/en active Pending
- 1998-11-12 BR BR9814127-9A patent/BR9814127A/en not_active IP Right Cessation
- 1998-11-12 CA CA002309542A patent/CA2309542A1/en not_active Abandoned
- 1998-11-12 WO PCT/US1998/024102 patent/WO1999024017A1/en not_active Ceased
- 1998-11-12 AU AU14569/99A patent/AU751117B2/en not_active Ceased
- 1998-11-12 JP JP2000520110A patent/JP2001522794A/en active Pending
2000
- 2000-05-11 NO NO20002439A patent/NO20002439D0/en unknown

Also Published As

Publication number	Publication date
AU1456999A (en)	1999-05-31
NO20002439L (en)	2000-05-11
WO1999024017A1 (en)	1999-05-20
HUP0004345A2 (en)	2001-06-28
EP1030651A4 (en)	2006-05-31
JP2001522794A (en)	2001-11-20
AU751117B2 (en)	2002-08-08
NO20002439D0 (en)	2000-05-11
TR200001362T2 (en)	2000-09-21
CN1285738A (en)	2001-02-28
NZ504418A (en)	2003-02-28
PL340456A1 (en)	2001-02-12
EP1030651A1 (en)	2000-08-30
KR20010031952A (en)	2001-04-16
BR9814127A (en)	2000-10-03
CA2309542A1 (en)	1999-05-20
HUP0004345A3 (en)	2001-10-29

Publication	Publication Date	Title
GB9613470D0 (en)	1996-08-28	Small solid oral dosage form
HUP0101437A3 (en)	2003-01-28	Oral pharmaceutical extended release dosage form
HUP0203204A3 (en)	2004-06-28	Oral dosage forms
PL322579A1 (en)	1998-02-02	2-methyl-thiene-benzodiazeoin prparation for oral administration
EP1020193A4 (en)	2006-05-24	Oral preparation
HUP9903407A3 (en)	2000-11-28	Oral pharmaceutical preparation containing ibandronat
EG23875A (en)	2007-11-27	Oral pharmaceutical pulsed release dosage form
ZA96365B (en)	1996-08-06	New oral pharmaceutical dosage form
GB9801363D0 (en)	1998-03-18	Novel dosage form
AU3977099A (en)	1999-12-13	Controlled release oral dosage form
AU7375598A (en)	1998-11-27	Stable oral pharmaceutical dosage forms
GB9700504D0 (en)	1997-02-26	Pharmaceutical compounds
PL335502A1 (en)	2000-04-25	Paracetamol containing oral tablet
IL138192A0 (en)	2001-11-25	Controlled release oral dosage forms
IL136028A0 (en)	2001-05-20	Novel oral dosage form for carvedilol
EP1003495A4 (en)	2002-08-28	Pharmaceutical compounds
ZA976189B (en)	1999-01-11	Oral pharmaceutical combinations
EP0953359A4 (en)	2001-12-19	Pharmaceutical composition for oral administration
PL338781A1 (en)	2000-11-20	Dosage form
EP1114642A4 (en)	2007-12-12	Drugs for periodontal diseases
GB9700895D0 (en)	1997-03-05	Pharmaceutical compounds
GB9718616D0 (en)	1997-11-05	Oral vaccine
ZA974125B (en)	1998-11-13	Oral pharmaceutical compositions
SG63838A1 (en)	1999-03-30	Oral composition
HUP0101012A3 (en)	2002-12-28	Pharmaceutical composition for oral administration

Legal Events

Date	Code	Title
2006-09-05	KB	Patent renewed
2009-06-15	KB	Patent renewed
2013-06-27	MM9K	Patent not in force due to non-payment of renewal fees